ARK Investment Management - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q3 2020$1,302,000
-85.5%
71,010
-88.2%
0.01%
-91.8%
Q2 2020$9,007,000
+42.5%
601,653
+50.6%
0.10%
-38.6%
Q1 2020$6,322,000
-5.5%
399,632
-3.0%
0.16%
-6.5%
Q4 2019$6,689,000
+28.8%
411,880
+17.8%
0.17%
+49.6%
Q3 2019$5,195,000
-0.0%
349,625
+11.2%
0.11%
-13.7%
Q2 2019$5,197,000
+5.1%
314,378
+10.0%
0.13%
-7.1%
Q1 2019$4,944,000285,7620.14%
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q3 2019.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders